Glenmede Trust CO Na Lantheus Holdings, Inc. Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 4,924 shares of LNTH stock, worth $398,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,924Holding current value
$398,056% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding LNTH
# of Institutions
536Shares Held
68.1MCall Options Held
665KPut Options Held
409K-
Black Rock Inc. New York, NY8.6MShares$695 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.42MShares$600 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$290 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.96MShares$239 Million1.63% of portfolio
-
State Street Corp Boston, MA2.52MShares$204 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $5.56B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...